2026-10-25
Blend Labs clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,630 −6.36%
S&P 7,354 −4.36%
GOLD $4,077 +0.10%
BTC $76,016 −5.46%
VIX 28.18 +69.66%
latest tape · as of 02:03 UTC
The Screen · Technology · Software - Application
Blend Labs Inc
BLND · the NYSE · USD · Market cap $277M · 419 employees
Blend Labs, Inc.
Not yet scored1.28 USD
Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 02:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price1.28 USD at the 4 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 4 Nov 2026
- Our regime readMarkup, as of 5 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.00)
- Last reviewed4 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $1.62 to $2.17, base estimate $1.89 (screen dated 2026-11-04).
- Trend Markup
- Insiders insiders sold, $23,911, latest filing 2026-10-26
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.00, read 2026-11-05
- Ethical screen not yet scored
Price1.28 USD
Fair value1.89
Ethical score70.0/100
Value readUndervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-10-28Read Markup1.17+9.4% to today ✓Markdown gives way to Markup after a 6% slide in 4 weeks
2026-10-02Read Markdown1.25+2.4% to today Distribution gives way to Markdown after a 19% slide in 6 weeks
2026-08-23Read Distribution1.55-17.4% to today ✓Markup gives way to Distribution after an 8% slide in 7 weeks
2026-07-02Read Markup1.69-24.3% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markup label.
Blend Labs Inc holds its Markup at $1.28. The statistical read favours the sellers, held for 11 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 11 days |
| Price at the screen | $1.28 |
| Valuation | N/A trailing · 19.50 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.08 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 0.87% | Below 33% | Interest-bearing debt is just 0.9% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 17.87% | Below 33% | Cash held in interest-bearing accounts and securities is 17.9% of assets, under the one-third limit. | Pass |
| Receivables | 30.79% | Below 49% | Money owed to the company is 30.8% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Blend Labs clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Blend Labs clears all five screens. Its business is in a permissible area, its debt is near-nil, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 4 Nov 2026: it trades at roughly a 32% discount to our $1.89 fair value, none competitive moat, 7.00% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 32.3% discount to the base estimate.
Third-party analyst targets. The average target sits +134% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $1.89, with a range of $1.62 to $2.17, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it stands out
A 7%-growth business trading at just 19.5x forward earnings, with a none competitive moat. That is a 32% discount to our $1.89 fair value: the market is pricing it cautiously while the fundamentals argue otherwise.
| Forward P/E | 19.5xexpensive even after accounting for its growth |
| EPS, trailing | -0.08 |
| EPS, forward | 0.06 |
| Revenue growth | +7.0%slow but positive growth |
| Profit margin | 0.0%barely profitable |
| Return on equity | 2.1%a modest return on shareholder capital |
| FCF yield | 8.49% |
| Debt to equity | 2.15heavy leverage: higher risk if revenue softens |
| Current ratio | 1.63healthy short-term liquidity |
| Beta | 1.08moves a little more than the market |
| Short interest, float | 0.05% |
| 52-week range | 0.88 - 3.62 |
| Moat | NONE |
| Market cap | $277M |
| Employees | 419 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeBLND trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-04
Markup $1.16
-0.9% Entry 10
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 53%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (5 analysts) rates it none, with a mean price target of $4. Insiders have been net sellers over the past quarter.
2026-10-28
Markup · changed $1.17
+17.0% Entry 9
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 17.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 53%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (5 analysts) rates it none, with a mean price target of $4. Insiders have been net sellers over the past quarter.
2026-10-21
Markdown $1.00
+0.4% Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.4% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 53%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (5 analysts) rates it none, with a mean price target of $4. Insiders have been net sellers over the past quarter.
2026-10-14
Markdown $1.00
-20.3% Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 20.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 53%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (5 analysts) rates it none, with a mean price target of $4. Insiders have been net sellers over the past quarter.
2026-10-02
Markdown · changed $1.25
-19.4% Entry 6
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 19.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 53%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (5 analysts) rates it none, with a mean price target of $4. Insiders have been net sellers over the past quarter. Since the last review it its composite score rose.
2026-08-23
Distribution · changed $1.55
-14.4% Entry 5
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 53%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (5 analysts) rates it none, with a mean price target of $4.
2026-07-23
Markup $1.81
+7.1% Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 53%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (5 analysts) rates it none, with a mean price target of $4.
2026-07-18
Markup $1.69
+0.0% Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 53%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (5 analysts) rates it none, with a mean price target of $4.
2026-07-03
Markup $1.69
+0.0% Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02
Markup $1.69
Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Blend Autopilot Gains Momentum as Tenth Lender Signs On Yahoo Finance · 25d ago
- Factual Data Brings its Affordable Credit Data Preview Tool into Blend Yahoo Finance · 29d ago
- Blend and Alliant Credit Union Partner to Reimagine the Journey to Homeownership Yahoo Finance · 23 Sep 2026
- Alliant Credit Union Partners with Blend to Reinvent the Digital Home Lending Experience Yahoo Finance · 9 Sep 2026
- Blend Honors Seven Customers With Best in Banking Awards at Forum 2026 Yahoo Finance · 27 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
IMMRImmersion Corp
XPERXperi Inc
AZA2Z Cust2Mate Solutions Corp
MTCMmtec Inc
CMRCCommerce.com Inc
SMRTSmartRent Inc
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-26 | Ghamsari Nima | HEAD OF BLEND | S - Sale | 21,368 | $23,911 |
| 2026-10-12 | Ghamsari Nima | HEAD OF BLEND | S - Sale | 25,098 | $24,471 |
| 2026-10-05 | Ghamsari Nima | HEAD OF BLEND | S - Sale | 24,272 | $24,660 |
| 2026-09-28 | Ghamsari Nima | HEAD OF BLEND | S - Sale | 22,523 | $24,820 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1.44 | +15.9% | · | $1,159 | +15.9% |
| 2 months | $1.42 | +17.6% | · | $1,176 | +17.6% |
| 3 months | $1.61 | +3.7% | · | $1,037 | +3.7% |
| 6 months | $3.33 | -49.9% | · | $501 | -49.9% |
| 1 year | $3.58 | -53.4% | · | $466 | -53.4% |
| 2 years | $2.64 | -36.8% | · | $632 | -36.8% |
| 3 years | $0.98 | +70.3% | · | $1,703 | +70.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever BLND does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.